Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease

Ghulam Murtaza; Mohit K. Turagam; Jalaj Garg; Urooge Boda; Krishna Akella; Poonam Velagapudi; Andrea Natale; Rakesh Gopinathannair; Dhanunjaya Lakkireddy

doi:10.1016/j.ipej.2021.04.002

Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease

Ghulam Murtaza
, Mohit K. Turagam
, Jalaj Garg
, Urooge Boda
, Krishna Akella
, Poonam Velagapudi
, Andrea Natale
, Rakesh Gopinathannair
, Dhanunjaya Lakkireddy

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	221-226
Number of pages	6
Journal	Indian Pacing and Electrophysiology Journal
Volume	21
Issue number	4
DOIs	https://doi.org/10.1016/j.ipej.2021.04.002
State	Published - Jul 1 2021
Externally published	Yes

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Keywords

Apixaban
Dialysis
End-stage renal disease
Meta-analysis
Warfarin

Access to Document

10.1016/j.ipej.2021.04.002

OpenUrl availability

Full text

Cite this

Murtaza, G., Turagam, M. K., Garg, J., Boda, U., Akella, K., Velagapudi, P., Natale, A., Gopinathannair, R., & Lakkireddy, D. (2021). Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease. Indian Pacing and Electrophysiology Journal, 21(4), 221-226. https://doi.org/10.1016/j.ipej.2021.04.002

Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease. / Murtaza, Ghulam; Turagam, Mohit K.; Garg, Jalaj et al.
In: Indian Pacing and Electrophysiology Journal, Vol. 21, No. 4, 01.07.2021, p. 221-226.

Research output: Contribution to journal › Article › peer-review

Murtaza, G, Turagam, MK, Garg, J, Boda, U, Akella, K, Velagapudi, P, Natale, A, Gopinathannair, R & Lakkireddy, D 2021, 'Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease', Indian Pacing and Electrophysiology Journal, vol. 21, no. 4, pp. 221-226. https://doi.org/10.1016/j.ipej.2021.04.002

Murtaza G, Turagam MK, Garg J, Boda U, Akella K, Velagapudi P et al. Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease. Indian Pacing and Electrophysiology Journal. 2021 Jul 1;21(4):221-226. doi: 10.1016/j.ipej.2021.04.002

Murtaza, Ghulam ; Turagam, Mohit K. ; Garg, Jalaj et al. / Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis : A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease. In: Indian Pacing and Electrophysiology Journal. 2021 ; Vol. 21, No. 4. pp. 221-226.

@article{558793ee7d62405aa718b604be760c20,

title = "Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease",

keywords = "Apixaban, Dialysis, End-stage renal disease, Meta-analysis, Warfarin",

author = "Ghulam Murtaza and Turagam, \{Mohit K.\} and Jalaj Garg and Urooge Boda and Krishna Akella and Poonam Velagapudi and Andrea Natale and Rakesh Gopinathannair and Dhanunjaya Lakkireddy",

note = "Publisher Copyright: {\textcopyright} 2021 Indian Heart Rhythm Society",

year = "2021",

month = jul,

day = "1",

doi = "10.1016/j.ipej.2021.04.002",

language = "English",

volume = "21",

pages = "221--226",

journal = "Indian Pacing and Electrophysiology Journal",

issn = "0972-6292",

number = "4",

}

TY - JOUR

T1 - Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis

T2 - A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease

AU - Murtaza, Ghulam

AU - Turagam, Mohit K.

AU - Garg, Jalaj

AU - Boda, Urooge

AU - Akella, Krishna

AU - Velagapudi, Poonam

AU - Natale, Andrea

AU - Gopinathannair, Rakesh

AU - Lakkireddy, Dhanunjaya

PY - 2021/7/1

Y1 - 2021/7/1

KW - Apixaban

KW - Dialysis

KW - End-stage renal disease

KW - Meta-analysis

KW - Warfarin

UR - https://www.scopus.com/pages/publications/85105288177

UR - https://www.scopus.com/pages/publications/85105288177#tab=citedBy

U2 - 10.1016/j.ipej.2021.04.002

DO - 10.1016/j.ipej.2021.04.002

M3 - Article

AN - SCOPUS:85105288177

SN - 0972-6292

VL - 21

SP - 221

EP - 226

JO - Indian Pacing and Electrophysiology Journal

JF - Indian Pacing and Electrophysiology Journal

IS - 4

ER -

Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis: Apixaban, End-Stage Renal Disease

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this